Results 11 to 20 of about 2,360,733 (398)

Reduced-Dose Deep Learning Reconstruction for Abdominal CT of Liver Metastases.

Radiology, 2022
Background Assessment of liver lesions is constrained as CT radiation doses are lowered; evidence suggests deep learning reconstructions mitigate such effects.
C. Jensen, Shiva Gupta, Mohammed M Saleh, Xinming Liu, Vincenzo K Wong, U. Salem, W. Qiao, E. Samei, N. Wagner-Bartak   +8 more
semanticscholar   +1 more source

Incidence and Survival in Synchronous and Metachronous Liver Metastases From Colorectal Cancer

JAMA Network Open, 2022
Key Points Question What are the differences in patterns of incidence and outcomes over time between synchronous and metachronous liver metastases from colorectal cancer?
Noémi Reboux, V. Jooste, J. Goungounga, M. Robaszkiewicz, J. Nousbaum, A. Bouvier   +5 more
semanticscholar   +1 more source

Recipient and Donor Outcomes After Living-Donor Liver Transplant for Unresectable Colorectal Liver Metastases

JAMA Surgery, 2022
This cohort study examines overall and recurrence-free survival outcomes in adult patients with liver-confined, unresectable colorectal cancer liver metastases who underwent a living-donor liver transplant.
R. Hernandez-Alejandro, L. Ruffolo, K. Sasaki, K. Tomiyama, M. Orloff, K. Pineda-Solís, A. Nair, J. Errigo, M. Dokus, M. Cattral, I. McGilvray, A. Ghanekar, S. Gallinger, N. Selzner, M. Claasen, R. Burkes, K. Hashimoto, M. Fujiki, C. Quintini, B. Estfan, C. Kwon, K. Menon, F. Aucejo, G. Sapisochin   +23 more
semanticscholar   +1 more source

Clinical Response to Immunotherapy Targeting Programmed Cell Death Receptor 1/Programmed Cell Death Ligand 1 in Patients With Treatment-Resistant Microsatellite Stable Colorectal Cancer With and Without Liver Metastases

JAMA Network Open, 2021
Key Points Question Is immunotherapy targeting programmed cell death receptor 1/programmed cell death ligand 1 (PD-1/PD-L1) associated with the presence of liver metastasis at the time of therapy and outcomes among patients with treatment-resistant ...
Chongkai Wang, J. Sandhu, C. Ouyang, Jiankui Ye, Peter P. Lee, M. Fakih   +5 more
semanticscholar   +1 more source

Successful radiofrequency ablation of liver metastases from prostate cancer

IJU Case Reports, 2022
Introduction Patients with liver metastases from prostate cancer show poor prognosis. We performed metastases‐directed therapy using radiofrequency ablation of liver metastases in an attempt to improve the prognosis in a patient with metastatic prostate ...
Daichi Hino, Takahiro Sugano, Mika Kino, Takako Nakata, Hiroki Kito, Masafumi Inoue, Hajime Fujie, Koichiro Akakura   +7 more
doaj   +1 more source

The Single‐Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer

Advancement of science, 2022
Distant metastasis remains the major cause of morbidity for breast cancer. Individuals with liver or brain metastasis have an extremely poor prognosis and low response rates to anti‐PD‐1/L1 immune checkpoint therapy compared to those with metastasis at ...
Yutian Zou, Feng Ye, Y. Kong, Xiaoqian Hu, X. Deng, Jindong Xie, Cailu Song, Xueqi Ou, Song Wu, Linyu Wu, Yi Xie, Wenwen Tian, Yuhui Tang, Chau-Wei Wong, Zhe‐Sheng Chen, Xinhua Xie, Hailin Tang   +16 more
semanticscholar   +1 more source

IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain.

Journal of Thoracic Oncology, 2021
INTRODUCTION Final overall survival (OS) analyses are presented for EGFR mutations and liver or brain metastases subgroups in the phase III IMpower150 study (NCT02366143) evaluating atezolizumab+bevacizumab+carboplatin/paclitaxel (ABCP) or atezolizumab ...
N. Nogami, F. Barlesi, M. Socinski, M. Reck, C. Thomas, F. Cappuzzo, T. Mok, G. Finley, J. Aerts, F. Orlandi, D. Moro-Sibilot, R. Jotte, D. Stroyakovskiy, L. Villaruz, D. Rodríguez-Abreu, D. Lim, D. Merritt, S. Coleman, Anthony Lee, G. Shankar, Wei Yu, I. Bāra, M. Nishio   +22 more
semanticscholar   +1 more source

Incidentally Detected Liver Metastases during Pancreas Contrast-enhanced Ultrasound

BIO Integration, 2021
Purpose: The purpose of current study was to investigate the value of the late-phase enhancement features of pancreas contrast-enhanced ultrasound (CEUS) in the detection of liver metastases in patients with pancreatic ductal adenocarcinomas (PDAC ...
Dan Zuo, Ji-Jiang Qian, Yi Dong, Wen-Ping Wang, Xiao-Fan Tian, Yi-Jie Qiu, Christoph Frank Dietrich   +6 more
doaj   +1 more source

Dendritic cell paucity in mismatch repair–proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy

Proceedings of the National Academy of Sciences of the United States of America, 2021
Significance Immune checkpoint blockade (ICB) has been efficacious in several cancer types. However, mismatch repair–proficient (pMMR) metastatic colorectal cancer (CRC), ∼95% of total metastatic CRC cases, typically does not respond to ICB.
William W. Ho, I. Gomes-Santos, S. Aoki, Meenal Datta, K. Kawaguchi, Nilesh P. Talele, S. Roberge, Jun Ren, Hao Liu, Ivy X. Chen, Patrik Andersson, Sampurna Chatterjee, A. Kumar, Zohreh Amoozgar, Qixian Zhang, P. Huang, M. Ng, Vikash P Chauhan, Lei Xu, D. Duda, Jeffrey W. Clark, M. Pittet, D. Fukumura, R. Jain   +23 more
semanticscholar   +1 more source

Adrenocortical carcinoma with multiple liver metastases controlled by bland transarterial embolization and surgery resulting in long-term survival

Radiology Case Reports, 2022
Adrenocortical carcinoma (ACC) is a rare malignant tumor with a poor prognosis. Local recurrence or distant metastases occur in more than 50% of cases. Patients with metastases have limited treatment options, and
Kiichi Watanabe, MD, Yoshihisa Kodama, MD, PhD, Yasuo Sakurai, MD, Beni Yamaguchi, MD, Koji Yamasaki, MD, Atsushi Ishiguro, MD, PhD, Yoshiyasu Ambo, MD, PhD   +6 more
doaj   +1 more source